Recombinant Human B4GALT4 (C-6His)

Description

EnkiLife provides the Recombinant Human B4GALT4 (C-6His) protein,aslo know as Beta-1;4-Galactosyltransferase 4,Beta-1;4-GalTase 4,Beta4Gal-T4,b4Gal-T4,UDP-Gal:Beta-GlcNAc Beta-1;4-Galactosyltransferase 4,UDP-Galactose:Beta-N-Acetylglucosamine Beta-1;4-Galactosyltransferase 4,B4GALT4, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Beta-1,4-Galactosyltransferase 4 is produced by our Mammalian expression system and the target gene encoding Gln39-Ala344 is expressed with a 6His tag at the C-terminus.Accession:O60513. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:36.77 KDa. Background:β-1,4-galactosyltransferase 4 (B4GALT4) is a single-pass type II membrane protein that belongs to the Glycosyltransferase 7 family. B4GALT4 consist of the following 2 domains: N-Acetyllactosamine Synthase and β-N-Acetylglucosaminyl-Glycolipid β-1,4-Galactosyltransferase. B4GALT4 is highly expressed in the heart, placenta, kidney, and pancreas; it is lowly expressed in the brain, colon, lung, muscle, ovary, testis, and uterus. B4GALT4 function is responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids.